In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype
Open Access
- 8 January 2004
- journal article
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 18 (3), 521-529
- https://doi.org/10.1038/sj.leu.2403253
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal regionThe Lancet, 2002
- Rapid and sensitive detection of all types of MLL gene translocations with a single FISH probe setLeukemia, 1999
- Cytogenetic studies of infant acute lymphoblastic leukemia: poor prognosis of infants with t(4;11) – a report of the Children’s Cancer GroupLeukemia, 1999
- Optimal immunocytochemical and flow cytometric detection of P-gp, MRP and LRP in childhood acute lymphoblastic leukemiaLeukemia, 1997
- The drug resistance-related protein LRP is the human major vault proteinNature Medicine, 1995
- Mononuclear cells contaminating acute lymphoblastic leukaemic samples tested for cellular drug resistance using the methyl-thiazol-tetrazolium assayBritish Journal of Cancer, 1994
- In vitro drug sensitivity of normal peripheral blood lymphocytes and childhood leukaemic cells from bone marrow and peripheral bloodBritish Journal of Cancer, 1991
- Detection of the Philadelphia chromosome in interphase nucleiCytogenetic and Genome Research, 1990
- Adaptation of the rapid automated tetrazolium dye based (MTT) assay for chemosensitivity testing in childhood leukemiaCancer Letters, 1988
- Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase IJournal of Molecular Biology, 1977